Aurinia Pharmaceuticals (IKAP) Cash flow

1 Followers

Aurinia Pharmaceuticals Cash Flow

DE:IKAP's free cash flow for Q2 2026 was $52.17M. For the 2026 fiscal year, DE:IKAP's free cash flow was decreased by $91.30M and operating cash flow was $52.17M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ 135.66M	$ 44.39M	$ -33.46M	$ -79.53M	$ -157.69M
Investing Cash Flow	$ -32.77M	$ 39.26M	$ -6.71M	$ -60.63M	$ -103.87M
Financing Cash Flow	$ -106.11M	$ -49.09M	$ -5.13M	$ 2.43M	$ 221.11M
End Cash Position	$ 80.21M	$ 83.43M	$ 48.88M	$ 94.17M	$ 231.90M
Free Cash Flow	$ 135.41M	$ 44.11M	$ -34.18M	$ -79.82M	$ -159.19M

Currency in USD